Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”

The USD 18 billion (by 2030) financial opportunity within the global cobots market has been analyzed across the following segments

Roots Analysis has done a detailed study on Global Collaborative Robots (Cobots) Market, 2020-2030.” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments

Roots Analysis is pleased to announce the publication of its recentstudy, titled, “GlobalCollaborative Robots (Cobots) Market, 2020-2030.”